Gupta Wealth Management’s Kite Pharma, Inc. KITE Stock Holding History

Gupta Wealth Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2K	Buy	+40	New	+$1.94K	﹤0.01%	1093

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gupta Wealth Management's KITE Position: Q1 2016 in Review

Gupta Wealth Management opened a new position in Kite Pharma, Inc. (KITE) in Q1 2016: 40 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1093 among its holdings.

171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Gupta Wealth Management held 40 shares of Kite Pharma, Inc. worth $2K as of Q1 2016.
Kite Pharma, Inc. was a new Gupta Wealth Management position in Q1 2016.
Kite Pharma, Inc. made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #1093 holding.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.